Cytokine levels in Crimean-Congo hemorrhagic fever
- PMID: 16765637
- DOI: 10.1016/j.jcv.2006.04.007
Cytokine levels in Crimean-Congo hemorrhagic fever
Abstract
Background: Crimean-Congo hemorrhagic fever (CCHF) virus causes severe disease in humans with a mortality reaching 30%. A CCHF outbreak took place in Albania in 2003. As in other viral hemorrhagic fevers cytokines may be involved and play a role in the pathogenesis and outcome of the disease.
Objectives: To investigate the levels of TNF-alpha, sTNF-R, IL-6 and IL-10 in serum samples obtained from laboratory confirmed CCHF cases and relate them to the severity of the disease.
Study design: A study population of 51 was divided into three groups: group A, consisting of PCR-positive cases; group B, consisting of PCR-negative and serology-positive cases; group C, consisting of doubly negative cases. Concentrations of serum TNF-alpha, sTNF-R, IL-6 and IL-10 were measured during the illness.
Results: High levels of all cytokines tested were present in one fatal case. Statistically significant differences between the groups were obtained for TNF-alpha and IL-6: TNF-alpha was detected in 3 cases in group A, and in none of the other groups, while IL-6 was elevated in 10/16 patients in group A, 4/9 in group B, and 4/26 in group C. sTNF-R was not significantly different for the three groups. High concentration of IL-10 was detected only in the fatal case.
Conclusions: TNF-alpha and IL-6 are the cytokines most often detected during a CCHF viral infection. TNF-alpha was associated with the severe form of CCHF, while IL-6 was elevated in both severe and mild cases.
Similar articles
-
Evaluation of serum levels of interleukin (IL)-6, IL-10, and tumor necrosis factor-alpha in patients with Crimean-Congo hemorrhagic fever.J Infect Dis. 2006 Apr 1;193(7):941-4. doi: 10.1086/500836. Epub 2006 Feb 22. J Infect Dis. 2006. PMID: 16518755
-
Immunohistochemical and in situ localization of Crimean-Congo hemorrhagic fever (CCHF) virus in human tissues and implications for CCHF pathogenesis.Arch Pathol Lab Med. 1997 Aug;121(8):839-46. Arch Pathol Lab Med. 1997. PMID: 9278612
-
Can the mild clinical course of crimean-congo hemorrhagic fever in children be explained by cytokine responses?J Med Virol. 2013 Nov;85(11):1955-9. doi: 10.1002/jmv.23697. Epub 2013 Jul 25. J Med Virol. 2013. PMID: 23893846
-
Crimean-Congo hemorrhagic fever.Antiviral Res. 2004 Dec;64(3):145-60. doi: 10.1016/j.antiviral.2004.08.001. Antiviral Res. 2004. PMID: 15550268 Review.
-
Crimean-Congo hemorrhagic fever in Iran and neighboring countries.J Clin Virol. 2010 Feb;47(2):110-4. doi: 10.1016/j.jcv.2009.10.014. Epub 2009 Dec 16. J Clin Virol. 2010. PMID: 20006541 Review.
Cited by
-
Characterization of a novel STAT 2 knock-out hamster model of Crimean-Congo hemorrhagic fever virus pathogenesis.Sci Rep. 2020 Jul 23;10(1):12378. doi: 10.1038/s41598-020-69054-3. Sci Rep. 2020. PMID: 32704046 Free PMC article.
-
Crimean-Congo hemorrhagic fever: epidemiological trends and controversies in treatment.BMC Med. 2011 Dec 8;9:131. doi: 10.1186/1741-7015-9-131. BMC Med. 2011. PMID: 22152109 Free PMC article.
-
Molecular Insights into Crimean-Congo Hemorrhagic Fever Virus.Viruses. 2016 Apr 21;8(4):106. doi: 10.3390/v8040106. Viruses. 2016. PMID: 27110812 Free PMC article. Review.
-
Immunocompetent mouse model for Crimean-Congo hemorrhagic fever virus.Elife. 2021 Jan 8;10:e63906. doi: 10.7554/eLife.63906. Elife. 2021. PMID: 33416494 Free PMC article.
-
Antibodies to the core proteins of Nairobi sheep disease virus/Ganjam virus reveal details of the distribution of the proteins in infected cells and tissues.PLoS One. 2015 Apr 23;10(4):e0124966. doi: 10.1371/journal.pone.0124966. eCollection 2015. PLoS One. 2015. PMID: 25905707 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials